|4Feb 23, 8:13 PM ET

Aklog Lishan 4

4 · Lucid Diagnostics Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
Aklog Lishan
DirectorChief Executive Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2022-02-18+75,00075,000 total
    Exercise: $3.95Exp: 2032-02-18Common stock (75,000 underlying)
Footnotes (1)
  • [F1]The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES